Study Evaluating Betrixaban in Pediatric Participants
Study Identifier:
16-021
ClinicalTrials.gov Identifier:
EudraCT Identifier:
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Other
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: Betrixaban
Date
Jul 2018 - Oct 2019
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 2 - 17 Years
Requirements Information
Sex
Female & Male
Age
2 - 17 Years
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: Betrixaban
Date
Jul 2018 - Oct 2019
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 2 - 17 Years years
Requirements Information
Protocol Summary
This trial was a Phase 1, open-label, multicenter study of the pharmacokinetics (PK), pharmacodynamics (PD), and safety of a single dose of betrixaban in pediatric participants at risk of venous thromboembolism (VTE).
Trial Locations
Location
Status
Location
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
Status
N/A
Location
ACTCA, Axis Clinical Trials
Los Angeles, California, United States, 90036
Status
N/A
Location
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
Status
N/A
Location
Tulane Medical Center
New Orleans, Louisiana, United States, 70001
Status
N/A
Location
Rainbow Babies & Children's Hospital
Cleveland, Ohio, United States, 44106
Status
N/A
Location
Children's Hospital of Tatarstan Republic
Kazan, Russian Federation, 420138
Status
N/A